CDTX vs JNJ: Which Stock is Better?
Side-by-side comparison of Cidara Therapeutics Inc and Johnson & Johnson in 2026
CDTX
Cidara Therapeutics Inc
—
JNJ
Johnson & Johnson
$232.77
Key Metrics Comparison
| Metric | CDTX | JNJ | Winner |
|---|---|---|---|
| Market Cap | $1.02B | $375.37B | JNJ |
| P/E Ratio | N/A | 17.35 | JNJ |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze CDTX
Full quant analysis
Analyze JNJ
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CDTX or JNJ a better investment?
Comparing CDTX and JNJ: Cidara Therapeutics Inc has a market cap of $1.02B while Johnson & Johnson has $375.37B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CDTX and JNJ?
CDTX (Cidara Therapeutics Inc) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CDTX or JNJ?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CDTX or JNJ?
Both CDTX and JNJ show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: CDTX or JNJ?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: CDTX or JNJ?
Johnson & Johnson (JNJ) is larger with a market cap of $375.37B compared to $1.02B for CDTX.
Should I buy CDTX or JNJ in 2026?
Both CDTX and JNJ have investment merit. CDTX trades at $N/A while JNJ trades at $232.77. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CDTX and JNJ stock?
Key differences: Market Cap ($1.02B vs $375.37B), P/E Ratio (N/A vs 17.4x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy CDTX or JNJ in 2026?
The choice between CDTX and JNJ depends on your investment goals. JNJ shows higher revenue growth (0.0%). JNJ has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between CDTX and JNJ?
CDTX (Cidara Therapeutics Inc) has a market cap of $1.02B, while JNJ (Johnson & Johnson) has a market cap of $375.37B. JNJ is the larger company by market value.